Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 848 participants.

Also called NCT07779746

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 848 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07779746
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07779746. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2031-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)
Acronym
SAFE-D2
Condition
End Stage Kidney Disease (ESRD)
Condition
Dialysis Patients
Intervention (Drug)
Eliquis
Intervention (Other)
No oral anticoagulation
Lead sponsor
Unity Health Toronto (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)

Record details

Record id
cardio:ct-nct07779746
Content hash
09d6271d65605d232e78870dc0bf9473cf2dd8f570c329da5c9bd12eb578aa6e